Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombosis 2Venous Thromboembolism 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Follicular 1Ischemic Stroke 1Hypertension, Portal 1Endometrial Neoplasms 1Cancer-associated Thrombosis 1

Interventions

Cyclophosphamide 81fludarabine phosphate 77Peripheral Blood Stem Cell Transplantation 62Mycophenolic Acid 55Tacrolimus 54Whole-Body Irradiation 52Busulfan 51Antilymphocyte Serum 45Cyclosporine 41fludarabine 36Methotrexate 32Filgrastim 32Melphalan 30Radiotherapy 25Methylprednisolone 19Cytarabine 17Cord Blood Stem Cell Transplantation 17Sirolimus 15Azacitidine 15Granulocyte Colony-Stimulating Factor 14Alemtuzumab 14thymoglobulin 13Flow Cytometry 13Etoposide 13Cyclosporins 13Specimen Handling 10Biopsy 10Thiotepa 9Psychiatric Rehabilitation 9Decitabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myeloproliferative Disorders × Anticoagulants × Clear all
NCT04527666 2020-08-27

Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

Shanghai Zhongshan Hospital

Unknown
40 enrolled
Myeloid

Hypertension, Portal, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡